About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Technicals
+12 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company News
Piramal Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:
543635
NSE Symbol:
PPLPHARMA
P/E :
26.18
ISIN Demat:
INE0DK501011
Div & Yield %:
0.1
EPS :
5.55
Book Value:
58.28
Market Cap (Rs. Cr.):
19,313.98
Face Value :
10
Date
Headline
05-Feb-26
Piramal Pharma announces cessation of director
29-Jan-26
Board of Piramal Pharma approves change in company secretary
16-Jan-26
Piramal Pharma to convene board meeting
24-Oct-25
Piramal Pharma to discuss results
21-Aug-25
Piramal Pharma Solutions opens dedicated OSD form suite at its facility in Sellersville, Pennsylvani
29-Jul-25
Piramal Pharma grants 20,20,507 stock options
22-Jul-25
Piramal Pharma to sell its decommissioned unit in MIDC, Thane for Rs 8.50 cr
21-Jul-25
Piramal Pharma receives upgrade in LT credit ratings
19-Jul-25
Piramal Pharma to announce Quarterly Result
14-Jun-25
Piramal Pharma to conduct AGM
Prev
1
2
3
Next